Marc Nasoff

Chief Scientific Officer, COI Pharmaceuticals.

Nasoff received his PhD in microbial genetics from the University of Maryland, which was followed by Postdoctoral training in organic synthesis at the University of Colorado. Nasoff brings to the board 35 years of industry experience, and currently serves as the Chief Scientific Officer of Biologics at COI Pharmaceuticals. Previously Nasoff served as the director of Biologics at GNF and worked closely with Novartis on the development of therapeutic antibodies. The goal of the GNF antibody program was to advance biotherapeutics into the Novartis drug discovery pipeline. Nasoff has authored over 50 patents and more than 30 publications.